[1] Washam J B, Stevens S R, Lokhnygina Y, et al. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes:a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)[J]. The Lancet, 2015, 385(9985): 2363-2370. [2] 任红心, 韩雷, 赵宁民, 等. 影响地高辛血药浓度的因素分析[J].中国医药科学, 2012, 2(19): 33-35. [3] Haiser H J, Gootenberg D B, Chatman K, et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta[J]. Science, 2013, 341(6143): 295-298. [4] 史惠卿, 胡婷婷, 雍小兰. 206 例地高辛血药浓度监测结果分析[J]. 西南军医, 2013, 15(5): 537-539. [5] Dobre D, Borer J S, Fox K, et al. Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties[J]. European journal of heart failure, 2014, 16(1): 76-85. [6] 陈舒晴, 王梓坤, 吴凡, 等. 北京大学第一医院地高辛血药浓度监测与影响因素分析[J]. 中国临床药理学杂志, 2016, 32(4):360-362. [7] Kubitza D, Becka M, Roth A, et al. Absence of clinically relevant interactions between rivaroxaban-an oral, direct Factor Xa inhibitor-and digoxin or atorvastatin in healthy subjects[J]. Journal of International Medical Research, 2012, 40(5): 1688-1707. [8] 瞿魏江, 倪慧. 我院地高辛血药浓度监测及结果分析[J]. 临床合理用药杂志, 2013, 6(1): 129-130. [9] Goldberger Z D, Goldberger A L. Therapeutic ranges of serum digoxin concentrations in patients with heart failure[J]. The American journal of cardiology, 2012, 109(12): 1818. [10] Lim A E, Tate J R, Clarke D, et al. Clinical consequences of a miscalibrated digoxin immunoassay[J]. Therapeutic drug monitoring,2015, 37(1): 104-109. [11] 郭健雄, 李超, 袁进, 等. 我院 436 例/次地高辛血药浓度监测结果分析[J]. 中国药房, 2015, 26(11): 1499-1501. [12] Konstantinou D M, Karvounis H, Giannakoulas G. Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker[J]. Cardiology, 2016, 134(3): 311-319. [13] Komatsu T, Morita M, Miyaji F, et al. Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patients[J].Journal of Pharmaceutical Health Care and Sciences, 2015, 1(1): 1. [14] 朱春香, 罗万慰, 夏军, 等. 我院 2011-2012 年 164 例次地高辛血药监测浓度回顾性分析[J]. 中国药房, 2014, 25(2): 136-139. [15] Welsh K J, Huang R S P, Actor J K, et al. Rapid Detection of the Active Cardiac Glycoside Convallatoxin of Lily of the Valley UsingLOCI Digoxin Assay[J]. American journal of clinical pathology,2014, 142(3): 307-312. |